RESUMO
Neuronal glycoprotein M6a is involved in neuronal plasticity, promoting neurite and filopodia outgrowth and, likely, synaptogenesis. Polymorphisms in the human M6a gene GPM6A have recently been associated with mental illnesses such as schizophrenia, bipolar disorders, and claustrophobia. Nevertheless, the molecular bases underlying these observations remain unknown. We have previously documented that, to induce filopodia formation, M6a depends on the association of membrane lipid microdomains and the activation of Src and mitogen-activated protein kinase kinases. Here, in silico analysis of the phosphorylation of tyrosine 251 (Y251) at the C-terminus of M6a showed that it could be a target of Src kinases. We examined whether phosphorylation of M6a at Y251 affects neurite and filopodia outgrowth and the targets involved in its signal propagation. This work provides evidence that the Src kinase family and the phosphatidylinositide 3-kinase (PI3K), but not Ras, participate in M6a signal cascade leading to neurite/filopodia outgrowth in hippocampal neurons and murine neuroblastoma N2a cells. Phosphorylation of M6a at Y251 is essential only for neurite outgrowth by the PI3K/AKT-mediated pathway and, moreover, rescues the inhibition caused by selective Src inhibitor and external M6a monoclonal antibody treatment. Thus, we suggest that phosphorylation of M6a at Y251 is critical for a specific stage of neuronal development and triggers redundant signaling pathways leading to neurite extension.
Assuntos
Glicoproteínas de Membrana/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Neuritos/fisiologia , Neurônios/citologia , Neurônios/metabolismo , Tirosina/metabolismo , Animais , Linhagem Celular Transformada , Cromonas/farmacologia , Embrião de Mamíferos , Inibidores Enzimáticos/farmacologia , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Hipocampo/citologia , Técnicas In Vitro , Masculino , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/genética , Camundongos , Morfolinas/farmacologia , Mutação/genética , Proteínas do Tecido Nervoso/química , Proteínas do Tecido Nervoso/genética , Neurônios/efeitos dos fármacos , Técnicas de Cultura de Órgãos , Fosfatidilinositol 3-Quinases/metabolismo , Fosforilação , Pseudópodes/fisiologia , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacosRESUMO
Chronic stress can trigger several pathologies including mood disorders for which no clear diagnostic molecular markers have been established yet. Attractive biomarker sources are extracellular vesicles (EVs). Evs are released by cells in health and disease and contain genetic material, proteins and lipids characteristic of the cell state. Here we show that Evs recovered from the blood of animals exposed to a repeated interrupted stress protocol (RIS) have a different protein profile compared to those obtained from control animals. Proteomic analysis indicated that proteins differentially present in bulk serum Evs from stressed animals were implicated in metabolic and inflammatory pathways and several of them were previously related to psychiatric disorders. Interestingly, these serum Evs carry brain-enriched proteins including the stress-responsive neuronal protein M6a. Then, we used an in-utero electroporation strategy to selectively overexpress M6a-GFP in brain neurons and found that M6a-GFP could also be detected in bulk serum Evs suggesting a neuronal origin. Finally, to determine if these Evs could have functional consequences, we administered Evs from control and RIS animals intranasally to naïve mice. Animals receiving stress EVs showed changes in behavior and brain M6a levels similar to those observed in physically stressed animals. Such changes could therefore be attributed, or at least in part, to EV protein transfer. Altogether these findings show that EVs may participate in stress signaling and propose proteins carried by EVs as a valuable source of biomarkers for stress-induced diseases.
Assuntos
Vesículas Extracelulares , Proteoma , Estresse Psicológico , Animais , Vesículas Extracelulares/metabolismo , Proteoma/metabolismo , Camundongos , Estresse Psicológico/sangue , Estresse Psicológico/metabolismo , Masculino , Comportamento Animal , Encéfalo/metabolismo , Proteômica/métodos , Neurônios/metabolismo , Camundongos Endogâmicos C57BLRESUMO
BACKGROUND: Members of the proteolipid protein family, including the four-transmembrane glycoprotein M6a, are involved in neuronal plasticity in mammals. Results from our group previously demonstrated that M6, the only proteolipid protein expressed in Drosophila, localizes to the cell membrane in follicle cells. M6 loss triggers female sterility, which suggests a role for M6 in follicular cell remodeling. These results were the basis of the present study, which focused on the function and requirements of M6 in the fly nervous system. RESULTS: The present study identified two novel, tissue-regulated M6 isoforms with variable N- and C- termini, and showed that M6 is the functional fly ortholog of Gpm6a. In the adult brain, the protein was localized to several neuropils, such as the optic lobe, the central complex, and the mushroom bodies. Interestingly, although reduced M6 levels triggered a mild rough-eye phenotype, hypomorphic M6 mutants exhibited a defective response to light. CONCLUSIONS: Based on its ability to induce filopodium formation we propose that M6 is key in cell remodeling processes underlying visual system function. These results bring further insight into the role of M6/M6a in biological processes involving neuronal plasticity and behavior in flies and mammals.
Assuntos
Comportamento Animal/fisiologia , Olho/metabolismo , Regulação da Expressão Gênica/fisiologia , Glicoproteínas de Membrana/fisiologia , Vias Visuais/metabolismo , Processamento Alternativo/genética , Animais , Animais Geneticamente Modificados , Linhagem Celular Tumoral , Clonagem Molecular , Sequência Conservada/genética , Drosophila , Proteínas de Drosophila/genética , Olho/ultraestrutura , Regulação da Expressão Gênica/genética , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Expectativa de Vida , Glicoproteínas de Membrana/genética , Microscopia Eletrônica de Varredura , Atividade Motora/genética , Mutação/genética , Neuroblastoma/patologia , Neurópilo/metabolismo , Neurópilo/ultraestrutura , Lobo Óptico de Animais não Mamíferos/metabolismo , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Pseudópodes/metabolismo , RNA Mensageiro/metabolismo , Transfecção , Vias Visuais/ultraestruturaRESUMO
Even though the understanding of the cause of early pregnancy loss due to chromosomal abnormalities has improved, there is a dearth of knowledge of the causes of loss in euploid conceptuses. Maternal infections are a cause of abort in humans, but the mechanisms are not clear, so we have developed a murine model to study the mechanism of septic abortion by inducing embryonic resorption (ER) with lipopolysaccharide (LPS). We demonstrated that augmented production of nitric oxide (NO) and prostaglandins (PG) is involved in ER, and that inhibitors of their synthesis could prevent ER. Also, we observed an increase in the oxidative damage, evidenced by nitration of tyrosine proteins, due to the peroxynitrite anion. Since an association between chronic marijuana smoking and early miscarriage has been shown in women, we studied the participation of anandamide (AEA), the principal endocannabinoid, on the mechanism of action of LPS. We showed that LPS-induced NO synthesis and tissue damage were mediated by AEA, and that this endotoxin inhibited AEA degradation and increased its synthesis. These results suggest that several inflammatory molecules participate in the mechanism of early pregnancy loss and that their modulation could be useful tools to prevent it.
Assuntos
Aborto Séptico/fisiopatologia , Aborto Espontâneo/fisiopatologia , Inflamação/fisiopatologia , Aborto Séptico/imunologia , Aborto Espontâneo/imunologia , Animais , Moduladores de Receptores de Canabinoides/metabolismo , Modelos Animais de Doenças , Embrião de Mamíferos/imunologia , Embrião de Mamíferos/metabolismo , Embrião de Mamíferos/fisiopatologia , Feminino , Humanos , Inflamação/imunologia , Mediadores da Inflamação/metabolismo , Camundongos , Óxido Nítrico/metabolismo , Nitritos/metabolismo , Gravidez , Prostaglandinas/metabolismoRESUMO
Anandamide binds to cannabinoid receptors and plays several central and peripheral functions. The aim of this work was to study the possible role for this endocannabinoid in controlling sperm-oviduct interaction in mammals. We observed that bull sperm and bovine oviductal epithelial cells express cannabinoid receptors, CB1 and CB2, and fatty acid amide hydrolase, the enzyme that controls intracellular anandamide levels. A quantitative assay to determine whether anandamide was involved in bovine sperm-oviduct interaction was developed. R(+)-methanandamide, a non-hydrolysable anandamide analog, inhibited sperm binding to and induced sperm release from oviductal epithelia. Selective CB1 antagonists (SR141716A or AM251) completely blocked R(+)-methanandamide effects. However, SR144528, a selective CB2 antagonist, did not exert any effect, indicating that only CB1 was involved in R(+)-methanandamide effect. This effect was not caused by inhibition of the sperm progressive motility or by induction of the acrosome reaction. Overall, our findings indicate for the first time that the endocannabinoid system is present in bovine sperm and oviductal epithelium and that anandamide modulates the sperm-oviduct interaction, by inhibition of sperm binding and induction of sperm release from oviductal epithelial cells, probably by activating CB1 receptors.
Assuntos
Ácidos Araquidônicos/fisiologia , Tubas Uterinas/metabolismo , Interações Espermatozoide-Óvulo/fisiologia , Espermatozoides/metabolismo , Amidoidrolases/antagonistas & inibidores , Amidoidrolases/metabolismo , Animais , Ácidos Araquidônicos/farmacologia , Benzamidas/farmacologia , Western Blotting/métodos , Canfanos/farmacologia , Carbamatos/farmacologia , Bovinos , Endocanabinoides , Epitélio/metabolismo , Feminino , Imuno-Histoquímica , Masculino , Microscopia de Fluorescência , Piperidinas/farmacologia , Alcamidas Poli-Insaturadas/farmacologia , Pirazóis/farmacologia , Receptor CB1 de Canabinoide/antagonistas & inibidores , Receptor CB1 de Canabinoide/metabolismo , Receptor CB2 de Canabinoide/antagonistas & inibidores , Receptor CB2 de Canabinoide/metabolismo , Motilidade dos Espermatozoides/efeitos dos fármacos , Interações Espermatozoide-Óvulo/efeitos dos fármacos , Espermatozoides/efeitos dos fármacosRESUMO
Anandamide is an endocannabinoid known to participate in reproductive processes. This study observed that 17beta-oestradiol and progesterone modulated the production of anandamide and its metabolizing enzymes in the rat uterus. Anandamide production was highest at the oestrous stage and 17beta-oestradiol and progesterone stimulated its synthesis in ovariectomized rats. During early pregnancy, anandamide production remained constant on days 1-5 of gestation and diminished towards day 6. On day 6, implantation sites showed lower synthesis compared with interimplantation sites. In the delayed implantation model, 17beta-oestradiol inhibited anandamide synthesis compared with progesterone. During pseudopregnancy, anandamide production did not decrease towards day 6 as occurred during normal gestation. The administration of 17beta-oestradiol augmented anandamide production in rats on day 5 of pseudopregnancy; the treatment with mifepristone did not produce any change in anandamide synthesis. Anandamide-metabolizing enzymes were regulated by progesterone and 17beta-oestradiol. The effect of ovarian hormones on the synthesis of anandamide depends on different physiological conditions, oestrous cycle and early pregnancy, and on the presence of the activated blastocyst. Thus, ovarian hormones, as signals that emanate from the mother, operate in conjunction with the blastocyst intrinsic programme, regulating the synthesis of anandamide in a specific manner during crucial reproductive events that may compromise pregnancy outcome.
Assuntos
Ácidos Araquidônicos/biossíntese , Estradiol/farmacologia , Progesterona/farmacologia , Útero/efeitos dos fármacos , Amidoidrolases/genética , Amidoidrolases/metabolismo , Animais , Moduladores de Receptores de Canabinoides/biossíntese , Implantação do Embrião/efeitos dos fármacos , Implantação do Embrião/genética , Endocanabinoides , Ciclo Estral/efeitos dos fármacos , Ciclo Estral/genética , Ciclo Estral/metabolismo , Feminino , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Ovariectomia , Fosfolipase D/genética , Fosfolipase D/metabolismo , Alcamidas Poli-Insaturadas , Gravidez , Pseudogravidez/genética , Pseudogravidez/metabolismo , Ratos , Ratos Wistar , Fatores de Tempo , Útero/metabolismoRESUMO
Prenatal stress (PS) induces molecular changes that alter neural connectivity, increasing the risk for neuropsychiatric disorders. Here we analyzed -in the hippocampus of adult rats exposed to PS- the epigenetic signature mediating the PS-induced neuroplasticity changes. Furthermore, using cultured hippocampal neurons, we investigated the effects on neuroplasticity of an epigenetic modulator. PS induced significant modifications in the mRNA levels of stress-related transcription factor MEF2A, SUV39H1 histone methyltransferase, and TET1 hydroxylase, indicating that PS modifies gene expression through chromatin remodeling. In in vitro analysis, histone acetylation inhibition with apicidin increased filopodium density, suggesting that the external regulation of acetylation levels might modulate neuronal morphology. These results offer a way to enhance neural connectivity that could be considered to revert PS effects.
Assuntos
Epigênese Genética , Código das Histonas , Plasticidade Neuronal , Efeitos Tardios da Exposição Pré-Natal/genética , Estresse Psicológico/genética , Animais , Células Cultivadas , Dioxigenases/genética , Dioxigenases/metabolismo , Feminino , Hipocampo/citologia , Hipocampo/crescimento & desenvolvimento , Hipocampo/metabolismo , Inibidores de Histona Desacetilases/farmacologia , Fatores de Transcrição MEF2/genética , Fatores de Transcrição MEF2/metabolismo , Masculino , Metiltransferases/genética , Metiltransferases/metabolismo , Neurogênese , Neurônios/citologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Peptídeos Cíclicos/farmacologia , Gravidez , Efeitos Tardios da Exposição Pré-Natal/metabolismo , Efeitos Tardios da Exposição Pré-Natal/fisiopatologia , Ratos , Ratos Sprague-Dawley , Ratos Wistar , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Estresse Psicológico/metabolismo , Estresse Psicológico/fisiopatologiaRESUMO
Membrane neuronal glycoprotein M6a is highly expressed in the brain and contributes to neural plasticity promoting neurite growth and spine and synapse formation. We have previously showed that chronic stressors alter hippocampal M6a mRNA levels in rodents and tree shrews. We now show that M6a glycoprotein can be detected in mouse blood. M6a is a transmembrane glycoprotein and, as such, unlikely to be free in blood. Here we demonstrate that, in blood, M6a is transported in extracellular vesicles (EVs). It is also shown that M6a-containing EVs are delivered from cultured primary neurons as well as from M6a-transfected COS-7 cells. Released EVs containing M6a can be incorporated into COS-7 cells changing its phenotype through formation of membrane protrusions. Thus, M6a-containing EVs might contribute to maintain cellular plasticity. M6a presence in blood was used to monitor stress effects. Chronic restraint stress modulated M6a protein level in a sex dependent manner. Analysis of individual animals indicated that M6a level variations depend on the stressor applied. The response to stressors in blood makes M6a amenable to further studies in the stress disorder field.
Assuntos
Vesículas Extracelulares/metabolismo , Glicoproteínas de Membrana/sangue , Proteínas do Tecido Nervoso/sangue , Estresse Fisiológico , Animais , Transporte Biológico , Biomarcadores , Células COS , Chlorocebus aethiops , Vesículas Extracelulares/ultraestrutura , Feminino , Imunofluorescência , Hipocampo/metabolismo , Masculino , Glicoproteínas de Membrana/líquido cefalorraquidiano , Glicoproteínas de Membrana/genética , Camundongos , Proteínas do Tecido Nervoso/líquido cefalorraquidiano , Proteínas do Tecido Nervoso/genética , Neurônios/metabolismo , Fatores SexuaisRESUMO
The aim of our study was to investigate if the lipopolysaccharide (LPS) differentially modulates throughout time the nitric oxide synthase (NOS) and cyclooxygenase (COX) enzymes in the estrogenized rat uterus. To study the effect of LPS throughout time on nitric oxide and prostaglandins production and on NOS and COX expression in the estrogenized rat uterus, females received 5 mg/kg intraperitoneally (i.p.) of LPS and were sacrificed 0.5, 1, 2, 3, 4 and 5 h post-administration. NO production was measured by arginine-citrulline conversion assay and prostaglandin E2/prostaglandin F2alpha by radioconversion. Enzyme expression was evaluated by Western blot analysis. The present work shows that LPS augmented NOS activity 3 h post-treatment and iNOS expression earlier, 2 h post-administration. On the other hand, the administration of LPS stimulated the production of prostaglandin E2/prostaglandin F2alpha and augmented the expression of COX-I 1 h after the treatment and of COX-II 2 h post-treatment. Meloxicam, a COX-II inhibitor, stimulated NO production in a group of rats injected i.p. with both LPS and the inhibitor and sacrificed 2 h after the treatment. These results indicate that, in the estrogenized rat uterus challenged with LPS, the early stimulation in the production of prostaglandins inhibited NOS activity, until the expression of the NOS isoforms is sufficient to overpass the inhibitory effect of the prostaglandins. The above findings suggest that the interaction between NOS and COX might be important in the regulation of physiopathologic events during pregnancy.
Assuntos
Dinoprosta/metabolismo , Dinoprostona/metabolismo , Lipopolissacarídeos/farmacologia , Óxido Nítrico Sintase Tipo II/metabolismo , Útero/enzimologia , Animais , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/metabolismo , Inibidores de Ciclo-Oxigenase 2/farmacologia , Estrogênios , Feminino , Meloxicam , Modelos Animais , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/metabolismo , Ratos , Ratos Wistar , Tiazinas/farmacologia , Tiazóis/farmacologia , Fatores de Tempo , Útero/efeitos dos fármacosRESUMO
Lipopolysaccharide (LPS) administration to mice on day 7 of gestation led to 100% embryonic resorption after 24 h. In this model, nitric oxide is fundamental for the resorption process. Progesterone may be responsible, at least in part, for a Th2 switch in the feto-maternal interface, inducing active immune tolerance against fetal antigens. Th2 cells promote the development of T cells, producing leukemia inhibitory factor (LIF), which seems to be important due to its immunomodulatory action during early pregnancy. Our aim was to evaluate the involvement of progesterone in the mechanism of LPS-induced embryonic resorption, and whether LIF can mediate hormonal action. Using in vivo and in vitro models, we provide evidence that circulating progesterone is an important component of the process by which infection causes embryonic resorption in mice. Also, LIF seems to be a mediator of the progesterone effect under inflammatory conditions. We found that serum progesterone fell to very low levels after 24 h of LPS exposure. Moreover, progesterone supplementation prevented embryonic resorption and LPS-induced increase of uterine nitric oxide levels in vivo. Results show that LPS diminished the expression of the nuclear progesterone receptor in the uterus after 6 and 12 h of treatment. We investigated the expression of LIF in uterine tissue from pregnant mice and found that progesterone up-regulates LIF mRNA expression in vitro. We observed that LIF was able to modulate the levels of nitric oxide induced by LPS in vitro, suggesting that it could be a potential mediator of the inflammatory action of progesterone. Our observations support the view that progesterone plays a critical role in a successful pregnancy as an anti-inflammatory agent, and that it could have possible therapeutic applications in the prevention of early reproductive failure associated with inflammatory disorders.
Assuntos
Anti-Inflamatórios/farmacologia , Perda do Embrião/induzido quimicamente , Perda do Embrião/prevenção & controle , Fator Inibidor de Leucemia/metabolismo , Lipopolissacarídeos/farmacologia , Progesterona/farmacologia , Animais , Anti-Inflamatórios/sangue , Suplementos Nutricionais , Perda do Embrião/sangue , Perda do Embrião/metabolismo , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Fator Inibidor de Leucemia/genética , Fator Inibidor de Leucemia/farmacologia , Camundongos , Camundongos Endogâmicos BALB C , Mifepristona/farmacologia , Óxido Nítrico/metabolismo , Gravidez , Progesterona/sangue , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores de Progesterona/metabolismo , Útero/efeitos dos fármacos , Útero/metabolismoRESUMO
We had previously shown that the transmembrane glycoprotein M6a, a member of the proteolipid protein (PLP) family, regulates neurite/filopodium outgrowth, hence, M6a might be involved in neuronal remodeling and differentiation. In this work we focused on M6, the only PLP family member present in Drosophila, and ortholog to M6a. Unexpectedly, we found that decreased expression of M6 leads to female sterility. M6 is expressed in the membrane of the follicular epithelium in ovarioles throughout oogenesis. Phenotypes triggered by M6 downregulation in hypomorphic mutants included egg collapse and egg permeability, thus suggesting M6 involvement in eggshell biosynthesis. In addition, RNAi-mediated M6 knockdown targeted specifically to follicle cells induced an arrest of egg chamber development, revealing that M6 is essential in oogenesis. Interestingly, M6-associated phenotypes evidenced abnormal changes of the follicle cell shape and disrupted follicular epithelium in mid- and late-stage egg chambers. Therefore, we propose that M6 plays a role in follicular epithelium maintenance involving membrane cell remodeling during oogenesis in Drosophila.
Assuntos
Proteínas de Drosophila/fisiologia , Proteínas de Membrana/fisiologia , Oogênese , Animais , Drosophila , Epitélio , Feminino , Folículo OvarianoRESUMO
Anandamide (AEA), a major endocannabinoid, binds to cannabinoid and vanilloid receptors (CB1, CB2 and TRPV1) and affects many reproductive functions. Nanomolar levels of anandamide are found in reproductive fluids including mid-cycle oviductal fluid. Previously, we found that R(+)-methanandamide, an anandamide analogue, induces sperm releasing from bovine oviductal epithelium and the CB1 antagonist, SR141716A, reversed this effect. Since sperm detachment may be due to surface remodeling brought about by capacitation, the aim of this paper was to investigate whether anandamide at physiological concentrations could act as a capacitating agent in bull spermatozoa. We demonstrated that at nanomolar concentrations R(+)-methanandamide or anandamide induced bull sperm capacitation, whereas SR141716A and capsazepine (a TRPV1 antagonist) inhibited this induction. Previous studies indicate that mammalian spermatozoa possess the enzymatic machinery to produce and degrade their own AEA via the actions of the AEA-synthesizing phospholipase D and the fatty acid amide hydrolase (FAAH) respectively. Our results indicated that, URB597, a potent inhibitor of the FAAH, produced effects on bovine sperm capacitation similar to those elicited by exogenous AEA suggesting that this process is normally regulated by an endogenous tone. We also investigated whether anandamide is involved in bovine heparin-capacitated spermatozoa, since heparin is a known capacitating agent of bovine sperm. When the spermatozoa were incubated in the presence of R(+)-methanandamide and heparin, the percentage of capacitated spermatozoa was similar to that in the presence of R(+)-methanandamide alone. The pre-incubation with CB1 or TRPV1 antagonists inhibited heparin-induced sperm capacitation; moreover the activity of FAAH was 30% lower in heparin-capacitated spermatozoa as compared to control conditions. This suggests that heparin may increase endogenous anandamide levels. Our findings indicate that anandamide induces sperm capacitation through the activation of CB1 and TRPV1 receptors and could be involved in the same molecular pathway as heparin in bovines.
Assuntos
Ácidos Araquidônicos/farmacologia , Moduladores de Receptores de Canabinoides/farmacologia , Alcamidas Poli-Insaturadas/farmacologia , Receptor CB1 de Canabinoide/metabolismo , Espermatozoides/efeitos dos fármacos , Espermatozoides/metabolismo , Canais de Cátion TRPV/metabolismo , Reação Acrossômica/efeitos dos fármacos , Animais , Bovinos , Relação Dose-Resposta a Droga , Endocanabinoides , Regulação da Expressão Gênica/efeitos dos fármacos , Heparina/farmacologia , Masculino , Transporte Proteico/efeitos dos fármacos , Receptor CB1 de Canabinoide/antagonistas & inibidores , Receptor CB2 de Canabinoide/antagonistas & inibidores , Receptor CB2 de Canabinoide/metabolismo , Espermatozoides/citologia , Canais de Cátion TRPV/antagonistas & inibidoresRESUMO
The release of arachidonic acid from membrane glycerophospholipids through the action of phospholipases (PLs) is the first step in the biosynthesis of prostaglandins (PGs). In reproductive tissues, the most important PLs are cytosolic PLA(2) (cPLA(2)) and types IIA and V of the secretory isoform (sPLA(2)). The aim of this work was to investigate the role of ovarian steroid hormones and oxytocin (OT) in the regulation of rat uterine PLA(2) activity and expression during pregnancy and labor. The activity of sPLA(2) increased near labor, whereas cPLA(2) activity augmented towards the end of gestation. The levels of sPLA(2) IIA and cPLA(2) mRNA showed an increase before labor (P<0.05, day 21), whereas sPLA(2) V mRNA was not regulated during pregnancy. The administration of atosiban (synthetic OT antagonist) together with tamoxifen (antagonist of estrogen receptors) was able to decrease cytosolic and secretory PLA(2) activities, diminish the expression of sPLA(2) IIA and cPLA(2), as well as decrease PGF(2 alpha) production before the onset of labor (P<0.01). The ovarian steroid did not affect PLA(2) during pregnancy. Collectively, these findings indicate that in the rat uterus, both 17beta-estradiol and OT could be regulating the activity and the expression of the secretory and the cytosolic isoforms of PLA(2), thus controlling PGF(2 alpha) synthesis prior to the onset of labor.
Assuntos
Estradiol/fisiologia , Isoenzimas/metabolismo , Trabalho de Parto/metabolismo , Ocitocina/fisiologia , Fosfolipases A2/metabolismo , Útero/enzimologia , Animais , Citosol/enzimologia , Dinoprosta/biossíntese , Dinoprosta/metabolismo , Estradiol/sangue , Antagonistas de Estrogênios/farmacologia , Feminino , Expressão Gênica/efeitos dos fármacos , Isoenzimas/genética , Mifepristona/farmacologia , Ocitocina/sangue , Fosfolipases A2/genética , Gravidez , Progesterona/antagonistas & inibidores , Progesterona/metabolismo , Ratos , Ratos Wistar , Receptores de Ocitocina/antagonistas & inibidores , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tamoxifeno/farmacologia , Útero/efeitos dos fármacos , Vasotocina/análogos & derivados , Vasotocina/farmacologiaRESUMO
We hypothesized that ethanol (EtOH) might act through the endocannabinoid system to inhibit luteinizing hormone-releasing hormone (LHRH) release. Therefore, we examined the mechanism by which EtOH and anandamide (AEA), an endogenous cannabinoid, inhibit LHRH release from incubated medial basal hypothalamic explants. In previous work, we demonstrated that EtOH inhibits the N-methyl-D-aspartic acid-stimulated release of LHRH by increasing the release of two neurotransmitters: beta-endorphin and gamma-aminobutyric acid (GABA). In the present work, bicuculline, a GABAergic antagonist, completely prevented the inhibition of AEA (10(-9)M) on N-methyl-D-aspartic acid-induced LHRH release, but naltrexone, a micro-opioid receptor antagonist, had no effect. AEA also significantly increased GABA release but had no effect on beta-endorphin release. Therefore, AEA could inhibit LHRH release by increasing GABA but not beta-endorphin release. Because EtOH and AEA acted similarly to inhibit LHRH release, we investigated whether both substances would affect the adenylate cyclase activity acting through the same GTP-coupled receptors, the cannabinoid receptors 1 (CB1-rs). AEA and EtOH (10(-1)M) reduced the forskolin-stimulated accumulation of cAMP, but AM251, a specific antagonist of CB1-r, significantly blocked that inhibition. Additionally we investigated whether CB1-r is involved in the inhibition of LHRH by EtOH and AEA. AEA and EtOH reduced forskolin-stimulated LHRH release, but AM251 significantly blocked that inhibition. Also, we demonstrated that EtOH did not act by increasing AEA synthase activity to inhibit LHRH release in our experimental conditions. Therefore, our results indicate that EtOH inhibits the release of LHRH acting through the endocannabinoid system.
Assuntos
Moduladores de Receptores de Canabinoides/metabolismo , Endocanabinoides , Etanol/farmacologia , Hormônio Liberador de Gonadotropina/metabolismo , Animais , Ácidos Araquidônicos/farmacologia , Bicuculina/farmacologia , Colforsina/farmacologia , AMP Cíclico/metabolismo , Hormônio Liberador de Gonadotropina/sangue , Hipotálamo Médio/efeitos dos fármacos , Hipotálamo Médio/metabolismo , Cinética , Masculino , N-Metilaspartato/farmacologia , Naltrexona/farmacologia , Alcamidas Poli-Insaturadas , Radioimunoensaio , Ratos , Ratos WistarRESUMO
Because Delta-9-tetrahydrocannabinol (THC) inhibited luteinizing hormone-releasing hormone (LHRH) in male rats, we hypothesized that the endocannabinoid, anandamide (AEA), would act similarly. AEA microinjected intracerebroventricularly (i.c.v.) decreased plasma luteinizing hormone (LH) at 30 min in comparison to values in controls (P < 0.001). The cannabinoid receptor 1 (CB1-r)-specific antagonist, [N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide] (AM251), produced a significant elevation in plasma LH (P < 0.01). AEA (10(-9) M) decreased LHRH release from medial basal hypothalami incubated in vitro. These results support the concept that endogenous AEA inhibits LHRH followed by decreased LH release in male rats. In ovariectomized (OVX) female rats, AEA i.c.v. also inhibited LH release, but in this case AM251 had an even greater inhibitory effect than AEA. In vitro, AEA had no effect on LHRH in OVX rats. It seems that endogenous AEA inhibits LHRH followed by decreased LH release in OVX rats but that AM251 has an inhibitory action in this case. In striking contrast, in OVX, estrogen-primed (OVX-E) rats, AEA i.c.v. instead of decreasing LH, increased its release. This effect was completely blocked by previous injection of AM251. When medial basal hypothalami of OVX-E rats were incubated, AEA increased LHRH release. The synthesized AEA was higher in OVX-E rats than in OVX and males, indicating that estrogen modifies endocannabinoid levels and effects. The results are interpreted to mean that sex steroids have profound effects to modify the response to AEA. It inhibits LHRH and consequently diminishes LH release in males and OVX females, but stimulates LHRH followed by increased LH release in OVX-E-primed rats.
Assuntos
Ácidos Araquidônicos/farmacologia , Estrogênios/farmacologia , Hormônio Liberador de Gonadotropina/metabolismo , Animais , Endocanabinoides , Feminino , Hormônios Esteroides Gonadais/farmacologia , Hormônio Liberador de Gonadotropina/efeitos dos fármacos , Hormônio Luteinizante/sangue , Masculino , Ovariectomia , Alcamidas Poli-Insaturadas , Ratos , Ratos Sprague-Dawley , Receptor CB1 de Canabinoide/efeitos dos fármacos , Receptor CB1 de Canabinoide/fisiologia , Fatores SexuaisRESUMO
El objeto del presente trabajo es investigar la capacidad de la desferrioxamina (DF) como quelante de hierro para disminuir o revertir una porfiria experimental severa inducida por hexaclorobenceno (HCB) en ratas. La DF se comienza a administrar después de 17 semanas de intoxicación con HCB y se continúa hasta la semana 27. Se cuantifican semanalmente excreciones en orina de ácido aminolevúlico (ALA), profobilinógeno y porfirinas. Al final del experimento se sacrifican los animales y se determinan porfirinas hepáticas y actividad de ALA sintetasa y porfirinógeno carboxi-liasa. Los resultados indican que el quelante adminsitrado no mejora el disturbio provocado por el HCB sobre el camino metabólico del hemo en las presentes condiciones. Se comparan estos resultados con los obtenidos cuando la DF se da conjuntamente con el HCB desde el comienzo de la administración del fungicida, situación en que sí el quelante retarda y atenúa el efecto porfirinogénico del HCB. Se discute el papel del hierro en la metabolización del HCB
Assuntos
Ratos , Animais , Desferroxamina/uso terapêutico , Porfirias/tratamento farmacológico , Dermatopatias/tratamento farmacológico , 5-Aminolevulinato Sintetase/metabolismo , 5-Aminolevulinato Sintetase/urina , Carboxiliases/metabolismo , Hexaclorobenzeno , Fígado/enzimologia , Porfobilinogênio/urina , Porfirias/induzido quimicamente , Porfirias/enzimologia , Porfirias/urina , Porfirinas/metabolismo , Porfirinas/urina , Indução de Remissão , Dermatopatias/induzido quimicamente , Dermatopatias/enzimologia , Dermatopatias/urinaRESUMO
La porfirinogeno carboxi-liase (PCL) esta severamente disminuida por accion del hexaclorobenceno (HCB) y otros hidrocarburos policlorados, que reproducen en animales una porfiria semejante a la porfiria cutanea tarda humana. El presente trabajo tiene por objeto establecer si la fuerte disminucion de la PCL observada en ratas porfiricas por HCB se debe a la presencia de algun inhibidor o a la modificacion de la estructura proteica de la enzima. Los primeros intentos realizados, que consistieron en ensayos cruzados y de calentamiento y en ensayos in vitro con hidrocarburos clorados y otros compuestos relacionados, permitieron detectar la presencia en el higado de los animales porfiricos de un inhibidor termoestable o parcialmente termoestable, de la PCL normal. Paralelamente se purifico la enzima proveniente de ratas normales e intoxicadas con HCB, con el objeto de analizar una serie de propiedades y de ellas deducir si la diferencia en actividad se debe a diferencias a nivel estructural. Con los metodos empleados hasta el momento se logro una purificacion de aproximadamente 110 veces. El efecto de dietilditiocarbamato de sodio, pirofosfato de sodio, ditiotreitol, temperatura pH, v 02 el comportamiento cromatografico y el PM, indicarian que pueden existir dichas diferencias estructurales